mRNA Coronavirus-19 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study
In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA COVID-19 vaccine-associated myopericarditis (VAM) was noted. Only one adolescent with life-threatening complications was reported with no deaths at any of the participating institutions.
source https://www.jpeds.com/article/S0022-3476(21)01231-2/fulltext?rss=yes
source https://www.jpeds.com/article/S0022-3476(21)01231-2/fulltext?rss=yes
Comments
Post a Comment